Indication and Usage: LEXIVA is indicated in combination with other antiretroviral agents for the treatment of HIV infection. The PI-experienced–patient study was not large enough to reach a definitive conclusion that LEXIVA/ritonavir and lopinavir/ritonavir are clinically equivalent. Once-daily administration of LEXIVA plus ritonavir is not recommended for PI-experienced patients or any pediatric patients. LEXIVA does not cure HIV or prevent passing HIV to others.
Important Safety Information: You should not take LEXIVA if you have had an allergic reaction to LEXIVA or AGENERASE® (amprenavir). Tell your healthcare provider if you have liver or kidney problems, have diabetes or hemophilia, are allergic to sulfa medicines, or are pregnant, planning to become pregnant, or breastfeeding. CONTINUED BELOW
ViiV Healthcare wants to help you get the drugs you need, even if you don't take our medicines. Learn more about how to save on medicines and ViiV Healthcare's available drug savings programs. Call us toll-free Monday through Friday at 1-866-GSK-FOR-U (1-866-475-3678) between 8:00 am and 8:00 pm Eastern Time.
Check Patient Savings for more assistance programs.
ViiV Healthcare's global community outreach gives hope to thousands of people in Africa and other regions of the developing world. These programs include research and development of new HIV medicines, preferential pricing of medicine, community investments, and innovative partnerships.
*Individual experiences may vary. By prescription only.
Talk to your doctor to see if LEXIVA is right for you.
Please see the full Prescribing Information for LEXIVA
LEXIVA is indicated in combination with other antiretroviral agents for the treatment of HIV infection.
LEXIVA does not cure HIV or prevent passing HIV to others.